Sensei Biotherapeutics, Inc. (SNSE) Financials

$9.01

$0.26 (-2.75%)
Last update: 01:00 PM EST
Day's range
$9.01
Day's range
$9.07
$0$0-$10M-$10M-$20M-$20M-$30M-$30M-$40M-$40M-$50M-$50MEarning201820182019201920202020202120212022202220232023202420245%5%4%4%3%3%2%2%1%1%0%0%Profit Margin
Profit Margin
Revenue
Earnings

SNSE Income statement / Annual

Last year (2024), Sensei Biotherapeutics, Inc.'s total revenue was $0.00, and the percentage change from the previous year is not available. In 2024, Sensei Biotherapeutics, Inc.'s net income was -$30.16 M. See Sensei Biotherapeutics, Inc.,s key income statements, including revenue, expenses, profit, and income.

Period FY-2024 FY-2023 FY-2022 FY-2021 FY-2020 FY-2019 FY-2018
Period Ended 12/31/2024 12/31/2023 12/31/2022 12/31/2021 12/31/2020 12/31/2019 12/31/2018
Operating Revenue $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Cost of Revenue $0.00 $571.00 K $1.81 M $685.00 K $209.00 K $73.00 K $44.00 K
Gross Profit $0.00 -$571.00 K -$1.81 M -$685.00 K -$209.00 K -$73.00 K -$44.00 K
Gross Profit Ratio 0 0 0 0 0 0 0
Research and Development Expenses $18.63 M $18.30 M $30.38 M $21.66 M $11.19 M $8.35 M $8.23 M
General & Administrative Expenses $13.04 M $18.67 M $19.81 M $15.82 M $7.53 M $4.09 M $4.51 M
Selling & Marketing Expenses $0.00 $100.00 K $0.00 $0.00 $0.00 $0.00 $0.00
Selling, General & Administrative Expenses $13.04 M $18.77 M $19.81 M $15.82 M $7.53 M $4.09 M $4.51 M
Other Expenses $951.00 K $0.00 $1.60 M $688.00 K -$649.00 K -$1.00 K $28.00 K
Operating Expenses $32.61 M $37.06 M $50.19 M $37.48 M $18.71 M $12.44 M $12.74 M
Cost And Expenses $0.00 $37.06 M $50.19 M $37.48 M $18.71 M $12.44 M $12.74 M
Interest Income $2.55 M $3.62 M $1.78 M $800.00 K $1.69 K $2.26 K $0.00
Interest Expense $90.00 K $144.00 K $219.00 K $670.00 K $1.69 M $2.26 M $327.00 K
Depreciation & Amortization $0.00 $3.68 M $1.81 M $685.00 K $209.00 K $73.00 K $44.00 K
EBITDA -$32.61 M -$33.39 M -$46.56 M -$36.80 M -$18.50 M -$12.36 M -$12.70 M
EBITDA Ratio 0 0 0 0 0 0 0
Operating Income Ratio 0 0 0 0 0 0 0
Total Other Income/Expenses Net $2.46 M $2.96 M $1.60 M $688.00 K -$649.00 K -$4.31 M -$299.00 K
Income Before Tax -$30.16 M -$34.10 M -$48.59 M -$36.79 M -$20.10 M -$16.74 M -$13.04 M
Income Before Tax Ratio 0 0 0 0 0 0 0
Income Tax Expense $0.00 $0.00 $219.00 K $670.00 K $529.00 K $2.26 M $299.00 K
Net Income -$30.16 M -$34.10 M -$48.81 M -$37.46 M -$20.63 M -$19.00 M -$13.04 M
Net Income Ratio 0 0 0 0 0 0 0
EPS -1.2 -1.22 -1.59 -1.35 -0.67 -0.65 -19.03
EPS Diluted -1.2 -1.22 -1.59 -1.35 -0.67 -0.65 -19.03
Weighted Average Shares Out $25.12 M $27.95 M $30.70 M $27.71 M $30.59 M $29.33 M $685.16 K
Weighted Average Shares Out Diluted $25.12 M $27.95 M $30.70 M $27.71 M $30.59 M $29.33 M $685.16 K
Link